Filing Details
- Accession Number:
- 0000059478-16-000294
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-02-03 13:50:14
- Reporting Period:
- 2016-02-01
- Filing Date:
- 2016-02-03
- Accepted Time:
- 2016-02-03 13:50:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 59478 | Lilly Eli & Co | LLY | Pharmaceutical Preparations (2834) | 350470950 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1513324 | F Stephen Fry | Lilly Corporate Center Indianapolis IN 46285 | Svp, Hr & Diversity | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-02-01 | 7,252 | $0.00 | 81,467 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-02-01 | 3,410 | $79.10 | 78,057 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2016-02-01 | 2,412 | $78.39 | 75,645 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-02-03 | 725 | $76.46 | 74,920 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Unit | Disposition | 2016-02-01 | 7,252 | $0.00 | 7,252 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2016-02-01 | 2016-02-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 159 | Indirect | 401(k) |
Footnotes
- The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2015.
- This transaction was executed in multiple trades at prices ranging from $78.19 to $78.65. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
Billionaire Hedge Funds
